David V Smith
CIK 1229447 · Executive Vice President & CFO · last filed 2025-06-12
David V Smith is an Executive Vice President & CFO who has filed 50 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for CDXS, was dated Jun 12, 2025. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $466.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$466.3K
6
50
-$1.39M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDXS | Director | 194,275 | $2.40 | $466.3K | -$62.2K | 12 | 2025-06-12 |
| IO Biotech, Inc. (IOBT) Delisted | Director | — | $0.05 | — | $0 | 5 | 2025-06-06 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Executive Vice President & CFO | 138,947 | $38.00 | $5.28M | $0 | 7 | 2021-04-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Executive Vice President & CFO | 40,000 | $178.75 | $7.15M | $0 | 2 | 2019-06-26 |
| ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Director | 9,500 | — | — | $0 | 6 | 2016-05-27 |
| THORATEC CORP (THOR) Delisted | CFO & EVP | 64,591 | — | — | -$1.33M | 18 | 2011-03-17 |
Recent Filings
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-12 | CDXS | Grant (A) | +40,983 | $0 | EDGAR |
| 2025-06-06 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | CDXS | Grant (A) | +30,120 | $0 | EDGAR |
| 2024-06-07 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | CDXS | Mixed | +23,329 | $0 | EDGAR |
| 2023-06-13 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | CDXS | Mixed | +6,477 | $0 | EDGAR |
| 2022-05-31 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-03 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | CDXS | Mixed | −4,156 | $0 | EDGAR |